TUMOR-SPECIFIC T-CELL IMMUNITY - READY FOR PRIME-TIME

被引：11

作者：

GREENBERG, PD

RIDDELL, SR

机构：

[1] UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA

[2] FRED HUTCHINSON CANC RES CTR, SEATTLE, WA 98104 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1992年 / 84卷 / 14期

关键词：

D O I：

10.1093/jnci/84.14.1059

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1059 / 1061

页数：3

共 18 条

[1] T-CELL IMMUNITY TO THE JOINING REGION OF P210BCR-ABL PROTEIN [J].

CHEN, W ;

PEACE, DJ ;

ROVIRA, DK ;

YOU, SG ;

CHEEVER, MA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) :1468-1472

[2] TREATMENT OF ESTABLISHED RENAL-CANCER BY TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-4 [J].

GOLUMBEK, PT ;

LAZENBY, AJ ;

LEVITSKY, HI ;

JAFFEE, LM ;

KARASUYAMA, H ;

BAKER, M ;

PARDOLL, DM .

SCIENCE, 1991, 254 (5032) :713-716

[3]

GREENBERG PD, 1991, ADV IMMUNOL, V49, P281

[4]

IOANNIDES CG, 1991, J IMMUNOL, V146, P1700

[5]

JEROME KR, 1991, CANCER RES, V51, P2908

[6] HUMAN LYMPHOCYTES-T RECOGNIZE A PEPTIDE OF SINGLE POINT-MUTATED, ONCOGENIC RAS PROTEINS [J].

JUNG, S ;

SCHLUESENER, HJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01) :273-276

[7]

KAHN M, 1991, J IMMUNOL, V146, P3235

[8] ANTITUMOR-ACTIVITY AND IMMUNE-RESPONSES INDUCED BY A RECOMBINANT CARCINOEMBRYONIC ANTIGEN-VACCINIA VIRUS-VACCINE [J].

KANTOR, J ;

IRVINE, K ;

ABRAMS, S ;

KAUFMAN, H ;

DIPIETRO, J ;

SCHLOM, J .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (14) :1084-1091

[9] TUMOR ANTIGENS [J].

KLEIN, G .

ANNUAL REVIEW OF MICROBIOLOGY, 1966, 20 :223-&

[10]

KWAK LW, 1990, BLOOD, V76, P2411

← 1 2 →